A Medical Records Based Study for Clinical Efficacy and Safety of ''clear lung detoxification soup'' in the treatment of Novel Coronavirus Pneumonia (COVID-19)
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003288
- Lead Sponsor
- Institute of Basic Research for Clinical Medicine, China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- Not specified
Comply with the diagnostic criteria for general type COVID-19 in the Diagnosis and Treatment Program for COVID-19(trial Inclusion criteria version 5th)
1. Patients who can not guarantee compliance of using TCM during the treatment period, or patients who are difficult to take medicine by oral or nasal route;
2. Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19;
3. Maternal, or patients with a positive urine pregnancy test;
4. People with malignant tumors, mental diseases and other systemic malignant diseases;
5. Those who are allergic to the test drug and those who are intolerant to the drug.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rate of survival;
- Secondary Outcome Measures
Name Time Method Physical and chemical indicators improvement time;Course of disease;time of hospitalization;Nucleic acid negative time;Time to improve clinical symptoms;